Cluster | Total UMI counts | Global CPM | Transcripts | Categories | Human homolog | Annotation |
---|---|---|---|---|---|---|
MligTC455_29290 | 207 | 4.31 | Mlig455_006941 | Neo: - |
SELENOI | Mlig455_006941 {REF} {Length: 2533} {Pfam: CDP-alcohol phosphatidyltransferase [PF01066.23, score=44.7]} {Human: ENSG00000138018, SELENOI, selenoprotein I, [Score=272, Expect=5e-88]} {Mouse: ENSMUSG00000075703, Selenoi, selenoprotein I, [Score=272, Expect=3e-88]} {Dmel: FBgn0053116, CG33116, [Score=275, Expect=5e-89]} {Celegans: WBGene00018797, F54D7.2, [Score=268, Expect=9e-87]} {Smed: dd_Smed_v6_6886_0_1, dd_Smed_v6_6886_0_1, [Score=291, Expect=5e-96]} {RNA1509_43108} {RNA1310_14774.1} {RNA815_18279} |
Region | logFC | logCPM | Pvalue | FDR | Specificity |
---|---|---|---|---|---|
RegionR1 | 1.659 | 2.676 | 0.26860 | 0.91921 | |
RegionR2 | -0.159 | 2.676 | 0.83724 | 1.00000 | |
RegionR3 | -0.328 | 2.676 | 0.59512 | 1.00000 | |
RegionR4 | 1.154 | 2.676 | 0.12401 | 0.35419 | |
RegionR5 | -0.359 | 2.676 | 0.54519 | 0.90733 | |
RegionR6 | -0.406 | 2.676 | 0.54148 | 1.00000 | |
RegionR7 | -0.503 | 2.676 | 0.55836 | 1.00000 | |
RegionR8 | -1.058 | 2.676 | 0.32645 | 0.95995 |
Region | logFC | logCPM | PValue | FDR | Specificity |
---|---|---|---|---|---|
RegenerationR1 | -5.872 | 2.676 | 0.23752 | 0.96582 | |
RegenerationR2 | 0.42 | 2.676 | 0.53808 | 0.88738 | |
RegenerationR3 | 0.387 | 2.676 | 0.61290 | 0.91390 | |
RegenerationR4 | -0.245 | 2.676 | 0.74957 | 0.96999 | |
RegenerationR5 | 0.439 | 2.676 | 0.53002 | 0.87490 | |
RegenerationR6 | 1.042 | 2.676 | 0.18080 | 0.51579 | |
RegenerationBL | 0.443 | 2.676 | 0.68493 | 1.00000 | |
RegenerationTP | 0.64 | 2.676 | 0.53252 | 0.92240 |
Nr. | Cluster | Total UMI counts | Global CPM | Transcripts | Categories | Human homolog | Σ Spearman correlations | Int1 | Int2 | Int3 | Reg1 | Reg2 | Reg3 | Annotation |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
1. | MligTC455_29290 | 207 | 4.31 | Mlig455_006941 | Neo: - |
SELENOI | 6 | 1.000 | 1.000 | 1.000 | 1.000 | 1.000 | 1.000 | Mlig455_006941 {REF} {Length: 2533} {Pfam: CDP-alcohol phosphatidyltransferase [PF01066.23, score=44.7]} {Human: ENSG00000138018, SELENOI, selenoprotein I, [Score=272, Expect=5e-88]} {Mouse: ENSMUSG00000075703, Selenoi, selenoprotein I, [Score=272, Expect=3e-88]} {Dmel: FBgn0053116, CG33116, [Score=275, Expect=5e-89]} {Celegans: WBGene00018797, F54D7.2, [Score=268, Expect=9e-87]} {Smed: dd_Smed_v6_6886_0_1, dd_Smed_v6_6886_0_1, [Score=291, Expect=5e-96]} {RNA1509_43108} {RNA1310_14774.1} {RNA815_18279} |
2. | MligTC455_39607 | 305 | 6.35 | Mlig455_049946 | Neo: - Age: - |
COL4A3BP | 1.819 | - | - | - | - | 0.962 | 0.857 | Mlig455_049946 {REF} {Length: 3668} {TRANSSPLICED} {Pfam: START domain [PF01852.21, score=65.9]; PH domain [PF00169.31, score=38.7]; Pleckstrin homology domain [PF15409.8, score=32.5]; Pleckstrin homology domain [PF15413.8, score=22.4]} {Human: ENSG00000113163, COL4A3BP, collagen type IV alpha 3 binding protein, [RH, Score=273, Expect=4e-84]} {Mouse: ENSMUSG00000021669, Col4a3bp, collagen, type IV, alpha 3 (Goodpasture antigen) binding protein, [Score=283, Expect=1e-85]} {Dmel: FBgn0027569, cert, ceramide transfer protein, [Score=261, Expect=2e-77]} {Celegans: WBGene00015646, mlt-10, [RH, Score=174, Expect=1e-45]} {Smed: dd_Smed_v6_5076_0_1, dd_Smed_v6_5076_0_1, [Score=174, Expect=2e-45]} {RNA1509_43762} {RNA1310_10709} {RNA815_11268} |
3. | MligTC455_32628 | 100 | 2.09 | Mlig455_024050 | Neo: - Age: - |
1.694 | - | - | 0.981 | - | 0.713 | - | Mlig455_024050 {REF} {Length: 682} {NoTransDecoderORF} {RNA1310_26279.1} {RNA815_17829.1} | |
4. | MligTC455_44114 | 182 | 3.79 | Mlig455_031764 | Neo: - Age: - |
PHKG2 | 1.677 | 0.705 | - | - | - | 0.972 | - | Mlig455_031764 {REF} {Length: 3526} {Pfam: Protein kinase domain [PF00069.27, score=239.4]; Protein tyrosine and serine/threonine kinase [PF07714.19, score=112.4]; WSC domain [PF01822.21, score=34.3]; Haspin like kinase domain [PF12330.10, score=24.2]; Lipopolysaccharide kinase (Kdo/WaaP) family [PF06293.16, score=19.7]; PhoP regulatory network protein YrbL [PF10707.11, score=19.1]; Phosphotransferase enzyme family [PF01636.25, score=18.8]; Kinase-like [PF14531.8, score=18.4]; Fungal protein kinase [PF17667.3, score=17.6]} {Human: ENSG00000156873, PHKG2, phosphorylase kinase catalytic subunit gamma 2, [Score=352, Expect=5e-116]; ENSG00000164776, PHKG1, phosphorylase kinase catalytic subunit gamma 1, [Score=351, Expect=1e-115]} {Mouse: ENSMUSG00000030815, Phkg2, phosphorylase kinase, gamma 2 (testis), [RH, Score=355, Expect=2e-117]} {Dmel: FBgn0011754, PhKgamma, Phosphorylase kinase gamma, [Score=354, Expect=4e-117]} {Celegans: WBGene00021753, Y50D7A.3, [Score=291, Expect=9e-92]} {Smed: dd_Smed_v6_7480_0_2, dd_Smed_v6_7480_0_2, [Score=214, Expect=2e-62]} {RNA1509_30070} {RNA1310_21069, RNA1509_30070} {RNA1509_30070, RNA815_11645} |
5. | MligTC455_49078 | 190 | 3.96 | Mlig455_047213 | Neo: - Age: Down-Up-Down |
EIF5A | 0.981 | - | - | - | - | 0.981 | - | Mlig455_047213 {REF} {Length: 1506} {Pfam: Eukaryotic elongation factor 5A hypusine, DNA-binding OB fold [PF01287.22, score=19.5]} {Human: ENSG00000132507, EIF5A, eukaryotic translation initiation factor 5A, [Score=100, Expect=8e-27]; ENSG00000253626, EIF5AL1, eukaryotic translation initiation factor 5A-like 1, [Score=99.0, Expect=4e-26]} {Mouse: ENSMUSG00000078812, Eif5a, eukaryotic translation initiation factor 5A, [Score=100, Expect=6e-27]} {Dmel: FBgn0285952, eEF5, eukaryotic translation elongation factor 5, [Score=89.0, Expect=1e-22]} {Celegans: WBGene00002065, iff-2, Eukaryotic translation initiation factor 5A-2, [Score=88.2, Expect=2e-22]} {Smed: dd_Smed_v6_966_0_1, dd_Smed_v6_966_0_1, [Score=79.0, Expect=5e-19]} {RNA1310_34057.1} {RNA815_20082} |
6. | MligTC455_07970 | 56 | 1.17 | Mlig455_033539 | Neo: - Age: - |
ZNF142 | 0.975 | - | - | - | - | 0.975 | - | Mlig455_033539 {REF} {Length: 3927} {Pfam: C2H2-type zinc-finger domain [PF13909.8, score=51.2]; Zinc finger, C2H2 type [PF00096.28, score=45.1]; Zinc-finger double domain [PF13465.8, score=44.1]; C2H2-type zinc finger [PF13894.8, score=19.6]} {Human: ENSG00000115568, ZNF142, zinc finger protein 142, [Score=107, Expect=2e-23]} {Mouse: ENSMUSG00000026135, Zfp142, zinc finger protein 142, [Score=80.9, Expect=3e-15]; ENSMUSG00000029249, Rest, RE1-silencing transcription factor, [Score=79.3, Expect=8e-15]} {Dmel: FBgn0001180, hb, hunchback, [RH, Score=189, Expect=4e-51]} {Celegans: WBGene00001824, hbl-1, Hunchback-like protein, [RH, Score=174, Expect=2e-45]} {Smed: dd_Smed_v6_47627_0_1, dd_Smed_v6_47627_0_1, [Score=296, Expect=9e-94]} {RNA1310_53058} {RNA815_35691} |
7. | MligTC455_30589 | 76 | 1.58 | Mlig455_014800, Mlig455_042626 | Neo: - Age: Up-Down-Up |
0.971 | - | - | - | - | 0.971 | - | Mlig455_014800 {REF} {Length: 4522} {Pfam: DNA polymerase type B, organellar and viral [PF03175.15, score=132.9]} {Celegans: WBGene00007723, C25F9.2, [Score=290, Expect=2e-84]} {RNA1509_4648} {RNA1310_3417} {RNA815_2072} Mlig455_042626 {REF} {Length: 4176} {Pfam: DNA polymerase type B, organellar and viral [PF03175.15, score=141.2]} {Celegans: WBGene00007723, C25F9.2, [Score=291, Expect=7e-85]} {RNA1509_4648} {RNA1310_2280.1} {RNA815_694.2} |
|
8. | MligTC455_17679 | 365 | 7.59 | Mlig455_007359, Mlig455_066674 | Neo: - Age: - Region-enriched R2: 2.744/0.00362 |
0.97 | - | - | - | - | 0.970 | - | Mlig455_007359 {REF} {Length: 1638} {RNA1509_18138} {RNA1310_24629} {RNA815_31762} Mlig455_066674 {REF} {Length: 1869} {RNA1509_18138, RNA1509_36034} {RNA1310_24629, RNA1509_18138, RNA1509_36034} {RNA1509_18138, RNA1509_36034, RNA815_31762} |
|
9. | MligTC455_27777 | 238 | 4.97 | Mlig455_019427, Mlig455_058392 | Neo: - Age: - |
ATAD5 | 0.969 | - | - | - | - | 0.969 | - | Mlig455_019427 {REF} {Length: 3940} {Human: ENSG00000176208, ATAD5, ATPase family, AAA domain containing 5, [RH, Score=73.6, Expect=1e-12]} {Mouse: ENSMUSG00000017550, Atad5, ATPase family, AAA domain containing 5, [RH, Score=72.8, Expect=1e-12]} {Dmel: FBgn0036574, elg1, enhanced level of genomic instability 1, [Score=48.9, Expect=1e-05]} {Celegans: WBGene00013156, Y53F4B.9, [Score=52.0, Expect=1e-06]} {RNA1509_17564} {RNA1310_10601.1} {RNA815_24292} Mlig455_058392 {REF} {Length: 4009} {Human: ENSG00000176208, ATAD5, ATPase family, AAA domain containing 5, [RH, Score=73.9, Expect=1e-12]} {Mouse: ENSMUSG00000017550, Atad5, ATPase family, AAA domain containing 5, [RH, Score=74.3, Expect=6e-13]} {Dmel: FBgn0036574, elg1, enhanced level of genomic instability 1, [Score=51.6, Expect=4e-06]} {Celegans: WBGene00013156, Y53F4B.9, [Score=53.9, Expect=6e-07]} {RNA1509_17564} {RNA1310_10601.1} {RNA815_24292} |
10. | MligTC455_22411 | 240 | 4.99 | Mlig455_027900 | Neo: - Age: - |
0.968 | - | - | - | - | 0.968 | - | Mlig455_027900 {REF} {Length: 3133} {RNA1509_30929, RNA1509_38512} {RNA1310_27672, RNA1509_30929, RNA1509_38512} {RNA1509_30929, RNA1509_38512, RNA815_26534} | |
11. | MligTC455_32073 | 43 | 0.9 | Mlig455_043621 | Neo: Irradiation Age: - Region-enriched R4: 3.888/0.00237 |
0.966 | - | - | - | - | 0.966 | - | Mlig455_043621 {REF} {Length: 2838} {RNA1509_45511} {RNA1310_28603.1} {RNA815_29511.1} | |
12. | MligTC455_28622 | 626 | 13.05 | Mlig455_028335, Mlig455_066149 | Neo: - Age: Down-Up-Down |
ANO7 | 0.965 | - | - | - | - | 0.965 | - | Mlig455_028335 {REF} {Length: 5358} {TRANSSPLICED} {Pfam: Calcium-activated chloride channel [PF04547.14, score=416.5]; Dimerisation domain of Ca+-activated chloride-channel, anoctamin [PF16178.7, score=98.7]} {Human: ENSG00000146205, ANO7, anoctamin 7, [Score=303, Expect=5e-88]} {Mouse: ENSMUSG00000034107, Ano7, anoctamin 7, [Score=303, Expect=6e-89]} {Dmel: FBgn0036235, CG6938, [Score=279, Expect=2e-78]} {Celegans: WBGene00010138, anoh-1, Anoctamin, [RH, Score=432, Expect=1e-137]} {Smed: dd_Smed_v6_4761_0_1, dd_Smed_v6_4761_0_1, [Score=310, Expect=7e-92]} {RNA1509_16739} {RNA1310_3159} {RNA815_709.1} Mlig455_066149 {REF} {Length: 4069} {TRANSSPLICED} {Pfam: Calcium-activated chloride channel [PF04547.14, score=416.3]; Dimerisation domain of Ca+-activated chloride-channel, anoctamin [PF16178.7, score=105.2]} {Human: ENSG00000146205, ANO7, anoctamin 7, [Score=301, Expect=6e-87]} {Mouse: ENSMUSG00000034107, Ano7, anoctamin 7, [Score=300, Expect=2e-87]} {Dmel: FBgn0036235, CG6938, [Score=280, Expect=3e-78]} {Celegans: WBGene00010138, anoh-1, Anoctamin, [RH, Score=440, Expect=5e-140]} {Smed: dd_Smed_v6_4761_0_1, dd_Smed_v6_4761_0_1, [Score=311, Expect=4e-92]} {RNA1509_16739} {RNA1310_3045} {RNA815_709.1} |
13. | MligTC455_46144 | 230 | 4.8 | Mlig455_037529 | Neo: - Age: logFC(26M/2M)=-0.234 |
PDS5A | 0.965 | - | - | - | - | 0.965 | - | Mlig455_037529 {REF} {Length: 7763} {TRANSSPLICED} {Pfam: FANCI solenoid 2 [PF14676.8, score=19.2]} {Human: ENSG00000121892, PDS5A, PDS5 cohesin associated factor A, [RH, Score=422, Expect=3e-123]; ENSG00000083642, PDS5B, PDS5 cohesin associated factor B, [RH, Score=421, Expect=2e-122]} {Mouse: ENSMUSG00000029202, Pds5a, PDS5 cohesin associated factor A, [RH, Score=426, Expect=1e-124]} {Dmel: FBgn0260012, pds5, precocious dissociation of sisters 5, [Score=339, Expect=7e-96]} {Smed: dd_Smed_v6_6701_1_3, dd_Smed_v6_6701_1_3, [Score=251, Expect=6e-67]} {RNA1509_7371} {RNA1310_1423.1} {RNA815_501} |
14. | MligTC455_53241 | 843 | 17.55 | Mlig455_042246, Mlig455_047087 | Neo: Germline Age: Up-Down-Down Region-specific R4: 2.703 Region-enriched R4: 2.353/0.00081 |
0.959 | - | - | - | 0.959 | - | - | Mlig455_042246 {REF} {Length: 3748} {TRANSSPLICED} {RNA1509_11212} {RNA1310_3043.1} {RNA815_7288} Mlig455_047087 {REF} {Length: 4185} {TRANSSPLICED} {RNA1509_11212} {RNA1310_3043.1} {RNA815_7288} |
|
15. | MligTC455_47510 | 253 | 5.28 | Mlig455_047257, Mlig455_047311 | Neo: - Age: - Region-enriched R6: 2.630/0.01711 |
HTR1A | 0.958 | - | - | - | - | 0.958 | - | Mlig455_047257 {REF} {Length: 4105} {Pfam: 7 transmembrane receptor (rhodopsin family) [PF00001.23, score=230.7]; Serpentine type 7TM GPCR chemoreceptor Srsx [PF10320.11, score=27.2]} {Human: ENSG00000178394, HTR1A, 5-hydroxytryptamine receptor 1A, [Score=285, Expect=4e-92]} {Mouse: ENSMUSG00000021721, Htr1a, 5-hydroxytryptamine (serotonin) receptor 1A, [RH, Score=290, Expect=6e-94]} {Dmel: FBgn0053517, Dop2R, Dopamine 2-like receptor, [Score=228, Expect=5e-67]} {Celegans: WBGene00004779, ser-4, SERotonin/octopamine receptor family; Serotonin receptor, [Score=256, Expect=1e-80]} {Smed: dd_Smed_v6_33009_0_1, dd_Smed_v6_33009_0_1, [Score=356, Expect=4e-119]} {RNA1310_23878} {RNA815_22159} Mlig455_047311 {REF} {Length: 2473} {Pfam: 7 transmembrane receptor (rhodopsin family) [PF00001.23, score=230.9]; Serpentine type 7TM GPCR chemoreceptor Srsx [PF10320.11, score=25.9]} {Human: ENSG00000178394, HTR1A, 5-hydroxytryptamine receptor 1A, [Score=287, Expect=1e-92]} {Mouse: ENSMUSG00000021721, Htr1a, 5-hydroxytryptamine (serotonin) receptor 1A, [RH, Score=289, Expect=1e-93]} {Dmel: FBgn0004573, 5-HT7, 5-hydroxytryptamine (serotonin) receptor 7, [Score=221, Expect=5e-66]} {Celegans: WBGene00004779, ser-4, SERotonin/octopamine receptor family; Serotonin receptor, [Score=257, Expect=3e-81]} {Smed: dd_Smed_v6_11236_0_1, dd_Smed_v6_11236_0_1, [RH, Score=276, Expect=4e-88]} {RNA1310_23878} {RNA815_22159} |
16. | MligTC455_25563 | 24 | 0.51 | Mlig455_015495 | Neo: - Age: - |
0.954 | - | - | - | - | 0.954 | - | Mlig455_015495 {REF} {Length: 1562} {NoTransDecoderORF} {RNA1509_48973} {RNA1310_27704} {RNA815_36286} | |
17. | MligTC455_23662 | 285 | 5.95 | Mlig455_025104 | Neo: Irradiation Age: - Region-specific R4: 5.419 Region-enriched R4: 3.777/0.00001 |
0.952 | - | - | - | - | 0.952 | - | Mlig455_025104 {REF} {Length: 4467} {RNA1509_23438} {RNA1310_48896, RNA1509_23438} | |
18. | MligTC455_43593 | 1419 | 29.57 | Mlig455_040044 | Neo: Irradiation Age: logFC(26M/2M)=0.529 Region-enriched R5: 1.148/0.01204 |
CDK1 | 0.952 | - | - | - | 0.952 | - | - | Mlig455_040044 {REF} {Length: 1638} {TRANSSPLICED} {Pfam: Protein kinase domain [PF00069.27, score=253.6]; Protein tyrosine and serine/threonine kinase [PF07714.19, score=124.6]; Haspin like kinase domain [PF12330.10, score=23.0]} {Human: ENSG00000170312, CDK1, cyclin dependent kinase 1, [RH, Score=412, Expect=3e-145]} {Mouse: ENSMUSG00000019942, Cdk1, cyclin-dependent kinase 1, [RH, Score=407, Expect=2e-143]} {Dmel: FBgn0004106, Cdk1, Cyclin-dependent kinase 1, [RH, Score=419, Expect=5e-148]} {Celegans: WBGene00000405, cdk-1, Cyclin-dependent kinase 1, [RH, Score=401, Expect=1e-140]} {Smed: dd_Smed_v6_31502_0_2, dd_Smed_v6_31502_0_2, [RH, Score=413, Expect=2e-145]} {RNA1509_15353, RNA1509_22915} {RNA1310_17831, RNA1509_15353, RNA1509_22915} {RNA1509_15353, RNA1509_22915, RNA815_7489.1} |
19. | MligTC455_24607 | 463 | 9.65 | Mlig455_025155 | Neo: Irradiation Age: Up-Down-Down, logFC(26M/2M)=-0.315 Region-specific R4: 3.785 Region-enriched R4: 3.975/0.00000 |
0.951 | - | - | - | 0.951 | - | - | Mlig455_025155 {REF} {Length: 4177} {RNA1509_3178, RNA1509_43438} {RNA1310_3011, RNA1509_3178, RNA1509_43438} {RNA1509_3178, RNA1509_43438, RNA815_901} | |
20. | MligTC455_42588 | 697 | 14.53 | Mlig455_059848 | Neo: - Age: - |
BRMS1L | 0.95 | - | - | - | - | - | 0.950 | Mlig455_059848 {REF} {Length: 1457} {TRANSSPLICED} {Pfam: Sds3-like [PF08598.13, score=45.0]} {Human: ENSG00000100916, BRMS1L, BRMS1 like transcriptional repressor, [RH, Score=102, Expect=3e-25]} {Mouse: ENSMUSG00000012076, Brms1l, breast cancer metastasis-suppressor 1-like, [RH, Score=102, Expect=2e-25]} {RNA1509_13906} {RNA1310_20862, RNA1509_13906} {RNA1509_13906, RNA815_8588} |
21. | MligTC455_49646 | 739 | 15.39 | Mlig455_067640 | Neo: - Age: - |
MEF2D | 0.95 | - | - | - | - | 0.950 | - | Mlig455_067640 {REF} {Length: 5061} {TRANSSPLICED} {Pfam: SRF-type transcription factor (DNA-binding and dimerisation domain) [PF00319.20, score=87.0]} {Human: ENSG00000116604, MEF2D, myocyte enhancer factor 2D, [Score=171, Expect=2e-50]; ENSG00000213999, MEF2B, myocyte enhancer factor 2B, [Score=170, Expect=3e-51]; ENSG00000064489, BORCS8-MEF2B, BORCS8-MEF2B readthrough, [Score=170, Expect=3e-51]; ENSG00000068305, MEF2A, myocyte enhancer factor 2A, [Score=167, Expect=3e-49]; ENSG00000081189, MEF2C, myocyte enhancer factor 2C, [Score=166, Expect=1e-52]} {Mouse: ENSMUSG00000001419, Mef2d, myocyte enhancer factor 2D, [Score=171, Expect=1e-50]; ENSMUSG00000030557, Mef2a, myocyte enhancer factor 2A, [Score=167, Expect=2e-49]; ENSMUSG00000005583, Mef2c, myocyte enhancer factor 2C, [Score=166, Expect=4e-53]} {Dmel: FBgn0011656, Mef2, Myocyte enhancer factor 2, [Score=162, Expect=3e-47]} {Celegans: WBGene00003182, mef-2, Related to vertebrate MEF2 transcription factor, [Score=174, Expect=2e-53]} {Smed: dd_Smed_v6_6889_0_1, dd_Smed_v6_6889_0_1, [Score=152, Expect=4e-44]} {RNA1509_58067, RNA1509_8265} {RNA1310_21974.1, RNA1509_58067, RNA1509_8265} {RNA1509_58067, RNA1509_8265, RNA815_4359.2} |